See more : GeneTether Therapeutics Inc. (GTTX.CN) Income Statement Analysis – Financial Results
Complete financial analysis of Cementir Holding N.V. (CEM.MI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cementir Holding N.V., a leading company in the Construction Materials industry within the Basic Materials sector.
- Chemomab Therapeutics Ltd. (CMMB) Income Statement Analysis – Financial Results
- Alumina Limited (AWCMF) Income Statement Analysis – Financial Results
- Zhejiang Viewshine Intelligent Meter Co.,Ltd (002849.SZ) Income Statement Analysis – Financial Results
- Nelly Group AB (publ) (NELLY.ST) Income Statement Analysis – Financial Results
- Union Auction Public Company Limited (AUCT-R.BK) Income Statement Analysis – Financial Results
Cementir Holding N.V. (CEM.MI)
About Cementir Holding N.V.
Cementir Holding N.V., together with its subsidiaries, manufactures and distributes grey and white cement, ready-mix concrete, aggregates, and concrete products in Nordic and Baltic, Belgium, North America, Turkiye, Egypt, and Asia Pacific. The company offers white cement under the Aalborg White brand for architectural, aesthetic, and structural applications; grey cement under the FUTURECEM brand; concrete for use in infrastructure, landscaping, industry and agriculture, energy and environment, buildings, and pre-stressed and prefabricated concrete products; and aggregates, such as natural sand, gravel, and crushed stones used in concrete and prefabricated products, asphalt, road foundations and engineering works, draining materials, and agricultural land applications. It also purchases and sells clinker, replacement parts, pet-coke and coal fuels, and other construction materials; and offers shipping and logistics services, procurement management services, assistance and technical support, goods forwarding, and digital solutions. Cementir Holding N.V. was incorporated in 1947 and is headquartered in Amsterdam, the Netherlands.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.70B | 1.72B | 1.36B | 1.22B | 1.22B |
| Cost of Revenue | 727.45M | 803.42M | 542.48M | 469.21M | 776.73M |
| Gross Profit | 967.88M | 919.68M | 817.50M | 755.58M | 441.53M |
| Gross Profit Ratio | 57.09% | 53.37% | 60.11% | 61.69% | 36.24% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 2.10M |
| General & Administrative | 17.03M | 15.45M | 14.05M | 14.66M | 0.00 |
| Selling & Marketing | 197.15M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 214.18M | 15.45M | 14.05M | 14.66M | 197.07M |
| Other Expenses | 0.00 | 11.75M | 10.01M | 8.90M | 0.00 |
| Operating Expenses | 216.38M | 739.82M | 647.92M | 612.84M | 199.17M |
| Cost & Expenses | 943.83M | 1.54B | 1.19B | 1.08B | 975.90M |
| Interest Income | 8.33M | 2.99M | 2.08M | 3.57M | 0.00 |
| Interest Expense | 13.11M | 11.07M | 8.68M | 12.81M | 8.54M |
| Depreciation & Amortization | 130.30M | 124.17M | 109.57M | 104.22M | 82.00M |
| EBITDA | 434.12M | 371.68M | 290.24M | 259.59M | 220.73M |
| EBITDA Ratio | 25.61% | 21.00% | 21.54% | 20.90% | 18.12% |
| Operating Income | 751.50M | 237.62M | 183.34M | 151.80M | 242.36M |
| Operating Income Ratio | 44.33% | 13.79% | 13.48% | 12.39% | 19.89% |
| Total Other Income/Expenses | -460.79M | -471.27M | -451.69M | -103.06M | -10.39M |
| Income Before Tax | 290.71M | 236.43M | 171.99M | 142.56M | 126.65M |
| Income Before Tax Ratio | 17.15% | 13.72% | 12.65% | 11.64% | 10.40% |
| Income Tax Expense | 75.22M | 54.88M | 48.99M | 33.20M | 36.22M |
| Net Income | 201.36M | 162.29M | 113.32M | 102.01M | 83.57M |
| Net Income Ratio | 11.88% | 9.42% | 8.33% | 8.33% | 6.86% |
| EPS | 1.29 | 1.04 | 0.72 | 0.64 | 0.53 |
| EPS Diluted | 1.29 | 1.04 | 0.72 | 0.64 | 0.53 |
| Weighted Avg Shares Out | 155.52M | 155.52M | 156.43M | 159.04M | 159.18M |
| Weighted Avg Shares Out (Dil) | 155.52M | 155.52M | 156.43M | 159.04M | 159.12M |
Source: https://incomestatements.info
Category: Stock Reports